Susquehanna International Group
CNST

Susquehanna International Group’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Susquehanna International Group’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-19,013
Closed -$643K – 14120
2021
Q2 		$643K Sell
19,013
-29,289
-61% -$746K ﹤0.01% 8951
2021
Q1 		$1.13M Buy
48,302
+23,892
+98% +$724K ﹤0.01% 7407
2020
Q4 		$703K Buy
24,410
+2,319
+10% +$58.4K ﹤0.01% 7531
2020
Q3 		$448K Sell
22,091
-19,723
-47% -$482K ﹤0.01% 7900
2020
Q2 		$1.26M Buy
41,814
+20,134
+93% +$725K ﹤0.01% 5404
2020
Q1 		$681K Buy
+21,680
New +$754K ﹤0.01% 6269

Susquehanna International Group's CNST Position: Q3 2021 in Review

Susquehanna International Group sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 19,013 shares — an estimated $643K sold.

Susquehanna International Group first reported a position in CNST in Q1 2020 and held it in 6 quarters. The position peaked at $1.26M in Q2 2020. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

  • Susquehanna International Group reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • Susquehanna International Group sold 19,013 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $643K.
  • Susquehanna International Group first reported a position in Constellation Pharmaceuticals, Inc. in Q1 2020 and held it in 6 quarters.
  • Susquehanna International Group's Constellation Pharmaceuticals, Inc. position peaked at $1.26M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Susquehanna International Group's 13F filing for Q3 2021, filed 15 Nov 2021.